DrugDashboards

Heparin Sodium

Heparin Sodium · HEPARIN SODIUM 5000 [USP'U]/mL · Injection, Solution · Intravenous; Subcutaneous · HF Acquisition Co LLC, DBA HealthFirst

NDC 51662-1460-01 · 1 mL in 1 CARTRIDGE · ANDA · View full market →

The short version

15 companies supply this market — deep enough that no single failure threatens the supply. It is in shortage right now — FDA lists the reason as “other”.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

All Part D pricing →

Matched to CMS's representative package for this drug (NDC 00781-3545-25) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.

ⓘ How this was built
Data sources
  • CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method

Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Plans pay at point of saleⓘ
$1.35per unit
middle half $1.08–$1.68 · 5,496 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $1.35
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
100%of plans cover it
tier 3 · prior auth 38% · step therapy 0% · qty limit 0%

*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 5 quarters since 2024.

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.6%chance of a new FDA shortage posting for heparin sodium (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 4× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $54.61 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA088100
TE code
—
Approval date
Apr 28, 1983
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0431-03)Nov 14, 2017
    month 106 — 5× the typical 20-month injectable shortage · model puts 30% odds it resolves within 6 months
  • In shortage now — Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0433-04)Nov 14, 2017
    month 106 — 5× the typical 20-month injectable shortage · model puts 30% odds it resolves within 6 months
  • In shortage now — Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-10)Nov 14, 2017
    month 106 — 5× the typical 20-month injectable shortage · model puts 30% odds it resolves within 6 months
  • In shortage now — Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-77)Nov 14, 2017
    Other
    month 106 — 5× the typical 20-month injectable shortage · model puts 30% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Heparin Sodium (Injection, Solution)

LabelerStrengthFirst seenLast seen
Baxter Healthcare CorporationHEPARIN SODIUM 200 [USP'U]/100mLJul 15, 2026Sep 3, 2026
Cardinal Health 107, LLCHEPARIN SODIUM 5000 [USP'U]/mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCHEPARIN SODIUM 1000 [USP'U]/mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCHEPARIN SODIUM 5000 [USP'U]/100mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCHEPARIN SODIUM 5000 [USP'U]/.5mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCHEPARIN SODIUM 10000 [USP'U]/100mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCHEPARIN SODIUM 5000 [USP'U]/mLJul 15, 2026Sep 3, 2026
Hepalink USA Inc.HEPARIN SODIUM 1000 [USP'U]/mLJul 15, 2026Sep 3, 2026
Hepalink USA Inc.HEPARIN SODIUM 5000 [USP'U]/mLJul 15, 2026Sep 3, 2026
HF Acquisition Co LLC, DBA HealthFirstHEPARIN SODIUM 10000 [USP'U]/mLJul 15, 2026Sep 3, 2026
Hospira, Inc.HEPARIN SODIUM 200 [USP'U]/100mLJul 15, 2026Sep 3, 2026
Hospira, Inc.HEPARIN SODIUM 5000 [USP'U]/100mLJul 15, 2026Sep 3, 2026
Medical Purchasing Solutions, LLCHEPARIN SODIUM 1000 [USP'U]/mLJul 15, 2026Sep 3, 2026
Sandoz Inc.HEPARIN SODIUM 1000 [USP'U]/mLJul 15, 2026Sep 3, 2026
Sandoz Inc.HEPARIN SODIUM 10000 [USP'U]/mLJul 15, 2026Sep 3, 2026
BE Pharmaceuticals Inc.HEPARIN SODIUM 2000 [USP'U]/2mLJul 15, 2026Sep 2, 2026
BE Pharmaceuticals Inc.HEPARIN SODIUM 5000 [USP'U]/.5mLJul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCHEPARIN SODIUM 5000 [USP'U]/.5mLJul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCHEPARIN SODIUM 1000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCHEPARIN SODIUM 10000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCHEPARIN SODIUM 20000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCHEPARIN SODIUM 10000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCHEPARIN SODIUM 200 [USP'U]/100mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.HEPARIN SODIUM 1000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.HEPARIN SODIUM 5000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Hepalink USA Inc.HEPARIN SODIUM 10000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Hepalink USA Inc.HEPARIN SODIUM 20000 [USP'U]/mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstHEPARIN SODIUM 5000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Hospira, Inc.HEPARIN SODIUM 5000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Hospira, Inc.HEPARIN SODIUM 1000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Meitheal Pharmaceuticals Inc.HEPARIN SODIUM 5000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Meitheal Pharmaceuticals Inc.HEPARIN SODIUM 5000 [USP'U]/.5mLJul 15, 2026Sep 2, 2026
Northstar Rx LLCHEPARIN SODIUM 10000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Northstar Rx LLCHEPARIN SODIUM 5000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Northstar Rx LLCHEPARIN SODIUM 1000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Phlow CorporationHEPARIN SODIUM 1000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Sagent PharmaceticalsHEPARIN SODIUM 1000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Sagent PharmaceticalsHEPARIN SODIUM 10000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Sagent PharmaceticalsHEPARIN SODIUM 5000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsHEPARIN SODIUM 10000 [USP'U]/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Heparin Sodium — NDC 51662-1460-01," retrieved September 3, 2026, https://drugdashboards.com/drug/51662146001.

Free to cite with attribution — see how the data is put together.